TG Therapeutics Inc (TGTX)
15.19
-0.40
(-2.57%)
USD |
NASDAQ |
Mar 28, 16:00
15.19
0.00 (0.00%)
After-Hours: 18:40
TG Therapeutics Gross Profit Margin (Quarterly): 82.14% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 82.14% |
September 30, 2023 | 97.88% |
June 30, 2023 | 88.11% |
March 31, 2023 | 89.02% |
December 31, 2022 | 96.25% |
September 30, 2022 | 97.87% |
June 30, 2022 | 96.13% |
March 31, 2022 | 88.24% |
December 31, 2021 | 90.95% |
September 30, 2021 | 85.62% |
June 30, 2021 | 90.42% |
March 31, 2021 | 82.47% |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.14%
Minimum
Dec 2023
97.88%
Maximum
Sep 2023
90.43%
Average
89.72%
Median
Gross Profit Margin (Quarterly) Benchmarks
Precision BioSciences Inc | -- |
Amicus Therapeutics Inc | 90.16% |
Geron Corp | -- |
Editas Medicine Inc | -- |
G1 Therapeutics Inc | 91.56% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 14.03% |
Return on Assets | 4.98% |
Return on Invested Capital | 7.75% |
Profit Margin (Quarterly) | -32.79% |
Operating Margin (Quarterly) | -28.39% |
Return on Net Operating Assets | 19.99% |